Interview: Cezary Sledziewski, Executive Director, PZPPF, Poland
Cezary Sledziewski, Executive Director of PZPPF, discusses the pros and cons of Poland’s catching up with EU’s rising standards. He argues: “No…
Interview: Rajmund I. Martyniuk, President, Polpharma, Poland
Polpharma , Poland’s role model and largest Polish manufacturer of drug products and active pharmaceutical ingredients, has pushed the Polish…
Interview: Tomasz Florkiewicz, General Manager, Mylan, Poland
Poland has an important manufacturing role for the CEE region and this is where Mylan has settled Agila, a state-of-the-art, high quality injectables…
Interview: Jerzy Toczyski, General Manager & President of…
GSK Poland's General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as…
Interview: Jerzy Toczyski, General Manager & President of the…
GSK Poland's General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as…
Interview: Jerzy Toczyski, General Manager & President of…
GSK Poland's General Manager, Jerzy Toczyski, explains the reasons behind acquiring a state-of-the-art manufacturing facility in Poland, as well as…
Interview: Paweł Przewięźlikowski, Co-founder & CEO,…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their…
Interview: Paweł Przewięźlikowski, Co-founder & CEO,…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their…
Interview: Paweł Przewięźlikowski, Co-founder & CEO,…
Selvita is one of Poland’s R&D jewels, and its co-founder and CEO, Paweł Przewięźlikowski, strongly wishes that others would join their…
Interview: Marynika Woroszylska-Sapieha, General Manager, Sanofi,…
Sanofi’s General Manager in Poland, Marynika Woroszylska-Sapieha, shares two very important concepts that showcase the situation in Poland, stating…
Interview: Waldemar Szwarczyński, Chairman of the Supervisory…
“Average pharmaceutical company expenditures on R&D are in the range of 13 to 15 percent of revenues: much higher than the global average, and…
Interview: Dariusz Nowicki, Director, Polfarmed, Poland
“The swelling influence of wholesalers in the market frightens me.” With three wholesalers in Poland holding 80 percent of the market and…